{"id":10170,"date":"2024-11-25T06:00:00","date_gmt":"2024-11-25T11:00:00","guid":{"rendered":"https:\/\/cov19longhaulfoundation.org\/?p=10170"},"modified":"2024-07-16T09:58:53","modified_gmt":"2024-07-16T14:58:53","slug":"study-long-covid-rates-are-expected-to-decline","status":"publish","type":"post","link":"https:\/\/cov19longhaulfoundation.org\/?p=10170","title":{"rendered":"Study: Long COVID Rates Are Expected to Decline"},"content":{"rendered":"\n<p class=\"has-small-font-size\"> July 2024 Newsmax Health<\/p>\n\n\n\n<p>People&#8217;s odds for long COVID appear to be declining with the advent of new variants of the virus, along with repeat infections and vaccinations, new research shows.<\/p>\n\n\n\n<p>That suggests that the average person&#8217;s chances of developing long-term symptoms is falling over time, concluded a team from Germany.<\/p>\n\n\n\n<p>&#8220;Although the cause of post-COVID-19 condition is still not fully understood, the outlook for the future for all those who have not yet developed post-COVID-19 is positive,&#8221; concluded study senior author&nbsp;<a href=\"https:\/\/www.medizin.uni-muenster.de\/en\/epi\/institute\/members-of-staff\/univ-prof-dr-med-andre-karch-msc.html\">Dr. Andr\u00e9 Karch<\/a>, from the University of M\u00fcnster.<\/p>\n\n\n\n<p>His team based its findings on a survey of almost 110,000 Germans, conducted in the fall of 2022.<\/p>\n\n\n\n<p>People were asked about whether (and when) they&#8217;d experienced long COVID, including symptoms such as physical exhaustion, cardiovascular problems and cognitive impairment.<\/p>\n\n\n\n<p>According to the World Health Organization, long COVID involves new or persistent symptoms that occur within three months of a COVID infection that can&#8217;t be explained by other causes.<\/p>\n\n\n\n<p>At the time of the online survey, over 80% of respondents said they had already gotten three or more COVID vaccines and 60% said they&#8217;d already been infected with the illness.<\/p>\n\n\n\n<p>About a third (35%) of those who said they&#8217;d had&nbsp;<a href=\"https:\/\/www.healthday.com\/a-to-z-health\/public-health\/covid-2665435130.html\">COVID-19<\/a>&nbsp;said they had also experienced at least one persistent symptom anywhere from four to 12 months after their infection, the researchers said.<\/p>\n\n\n\n<p>Among this subgroup, a quarter said they had nine or more symptoms commonly linked to long COVID.<\/p>\n\n\n\n<p>However, there were some encouraging long-term trends.<\/p>\n\n\n\n<p>First of all, rates of long COVID were lowest among people who&#8217;d been infected with the latest COVID variant, omicron, the team found.<\/p>\n\n\n\n<p>Long COVID rates were higher among those infected with the earliest (&#8220;wild type&#8221;) variant circulating in late 2020, the alpha variant circulating in early 2021, or the delta variant that dominated between July and December of 2021, the study found.<\/p>\n\n\n\n<p>&#8220;As our analysis indicates, the virus variant has an impact on the risk of post-COVID-19 condition,&#8221; said study lead author&nbsp;<a href=\"https:\/\/www.umh.de\/en\/portraets\/prof-dr-rafael-mikolajczyk\">Dr. Rafael Mikolajczyk<\/a>. He directs the Institute of Medical Epidemiology, Biometrics and Informatics at University Medicine Halle.<\/p>\n\n\n\n<p>&#8220;The risk appears to decrease with the new virus variants,&#8221; he explained in a news release from Halle and the German National Cohort. &#8220;An omicron infection was substantially less frequently associated with post-COVID-19 condition than earlier virus variants.&#8221;<\/p>\n\n\n\n<p>Perhaps counterintuitively, a person&#8217;s odds for long COVID also appeared to decline the more times they had been infected.<\/p>\n\n\n\n<p>&#8220;Those who did not develop post-COVID-19 condition after an infection and were infected again had a lower risk of post-COVID-19 condition than people who were infected for the first time,&#8221; Mikolajczyk noted.<\/p>\n\n\n\n<p>Getting a COVID vaccine for a fourth time also appeared to cut a person&#8217;s odds for long COVID.<\/p>\n\n\n\n<p>That may be because repeat vaccination lowers the odds that a person&#8217;s case of COVID-19 will be severe.<\/p>\n\n\n\n<p>So, even if &#8220;previous vaccinations did not directly protect against post-COVID-19 condition, indirect protection can be assumed&#8221; over time, Mikolajczyk said. &#8220;This is because, according to the data currently available, those vaccinated had a lower probability of developing symptomatic coronavirus infections or suffering a severe infection.&#8221;<\/p>\n\n\n\n<p>It&#8217;s been noted in prior research that a person&#8217;s odds for long COVID rises along with the severity of their initial infection.<\/p>\n\n\n\n<p>Finally, the time elapsed between a COVID shot and the onset of a new case of COVID-19 appeared to matter, in terms of the likelihood of developing long COVID.<\/p>\n\n\n\n<p>Specifically, the German team found that &#8220;if a coronavirus infection occurred within three months of vaccination, participants were more likely to report post-COVID-19 condition than people who had the infection at a longer interval from vaccination,&#8221; according to the news release.<\/p>\n\n\n\n<p>The findings were reported recently in the&nbsp;<em><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/38897239\/\">Journal of Infection<\/a><\/em>.<\/p>\n\n\n\n<p>Overall, folks&#8217; odds for developing long COVID may be declining over time, &#8220;given both the reduced risk resulting from omicron infections and the massively reduced risk for those who already had a SARS-CoV-2 infection which was not followed by post-COVID-19 symptoms,&#8221; Karch said.<\/p>\n\n\n\n<p>&#8220;Our results are in line with the fact that the incidence of post-COVID-19 condition, as observed last winter, is decreasing substantially,&#8221; he added.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>July 2024 Newsmax Health People&#8217;s odds for long COVID appear to be declining with the advent of new variants of the virus, along with repeat infections and vaccinations, new research [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":10172,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[149,289,290],"tags":[],"class_list":["post-10170","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-epidemiology","category-long-haul-disease","category-long-term-effects"],"_links":{"self":[{"href":"https:\/\/cov19longhaulfoundation.org\/index.php?rest_route=\/wp\/v2\/posts\/10170","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cov19longhaulfoundation.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cov19longhaulfoundation.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cov19longhaulfoundation.org\/index.php?rest_route=\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/cov19longhaulfoundation.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=10170"}],"version-history":[{"count":1,"href":"https:\/\/cov19longhaulfoundation.org\/index.php?rest_route=\/wp\/v2\/posts\/10170\/revisions"}],"predecessor-version":[{"id":10171,"href":"https:\/\/cov19longhaulfoundation.org\/index.php?rest_route=\/wp\/v2\/posts\/10170\/revisions\/10171"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cov19longhaulfoundation.org\/index.php?rest_route=\/wp\/v2\/media\/10172"}],"wp:attachment":[{"href":"https:\/\/cov19longhaulfoundation.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=10170"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cov19longhaulfoundation.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=10170"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cov19longhaulfoundation.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=10170"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}